Speech recognition with the MPEAK and SPEAK speech-coding strategies of the Nucleus Cochlear Implant.
The Spectra 22 Speech Processor and spectral peak (SPEAK) speech-coding strategy provide Nucleus 22 Channel Cochlear Implant (Cochlear, Corp., Englewood, Colo.) users with a better understanding of speech than the previous Mini Speech Processor and Multipeak (MPEAK) speech-coding strategy. On the NU-6 Monosyllabic Word Test, subjects scored 13% higher for words and 14% higher for phonemes with the SPEAK strategy than with the MPEAK strategy. On the Connected Speech Test and the CID Everyday Sentence Test, subjects scored 32% and 37% higher, respectively, with SPEAK than with MPEAK.
Holden
L K
LK
Department of Otolaryngology-Head and Neck Surgery, Washington Univeristy School of Medicine, St. Louis, MO 63110, USA.
Skinner
M W
MW
Holden
T A
TA
D000328:Adult; D000368:Aged; D003054:Cochlear Implants; D003143:Communication Devices for People with Disabilities; D003638:Deafness / Q000209:etiology / Q000534:rehabilitation*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010700:Phonetics; D013063:Speech Discrimination Tests; D013067:Speech Perception